Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217217 · ClinicalTrials.gov registry record · Phase 3
Low Field Magnetic Stimulation Treatment for Bipolar Depression
A Phase 3 study, sponsored by Mclean Hospital.
- Terminated
- Registry status
- Phase 3
- Development phase
- 13
- Enrollment target
NCT00217217 is a Phase 3 study that was terminated before completion, run by Mclean Hospital. The registered enrollment target is 13 participants.
The verdict
NCT00217217, a Phase 3 study, was terminated before completion, sponsored by Mclean Hospital.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 13 participants
- Enrollment target
Study Summary
Individuals with bipolar depression who had a particular kind of brain imaging reported improved mood after the imaging. This effect may be linked to the changing magnetic fields used during these magnetic resonance imaging studies. The current studies are designed to further explore the important parameters of this effect and to clarify the degree and duration of the mood effects.
Interventions
- DEVICE Echo-Planar Magnetic Resonance Imaging (EP-MRSI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2004-09 |
| Est. Completion | 2012-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00217217
The ClinicalTrials.gov registry entry for NCT00217217 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Echo-Planar Magnetic Resonance Imaging (EP-MRSI) is the first listed.
NCT00217217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00217217 about?
NCT00217217 is a clinical study titled "Low Field Magnetic Stimulation Treatment for Bipolar Depression". Individuals with bipolar depression who had a particular kind of brain imaging reported improved mood after the imaging. This effect may be linked to the changing magnetic fields used during these magnetic resonance imaging studies. The current studies are designed to further explore the important p...
What is the current status of trial NCT00217217?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 13 participants. The study started on 2004-09. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00217217?
The interventions under investigation include: Echo-Planar Magnetic Resonance Imaging (EP-MRSI) (DEVICE).
Who is sponsoring clinical trial NCT00217217?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.